From: Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers
P value
Hazard Ratio
95% CI for hazard ratio
RAD21
0.029
1.74
1.06 to 2.86
Grade
0.018
1.63
1.09 to 2.44
Size > 20 mm
0.656
1.11
0.71 to 1.73
Lymph node status
0.023
1.69
1.07 to 2.65
ER
0.003
0.46
0.28 to 0.77
Age > 50
0.325
1.28
0.781 to 2.11